Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 3.78% | 75.60 | 1.0% | $2164.57m | |
| AMGN | Amgen, Inc. | 4.33% | 206.86 | 1.3% | $952.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.63% | 474.84 | 2.6% | $819.23m | |
| BIIB | Biogen, Inc. | 7.69% | 319.56 | 1.5% | $766.58m | |
| MRNA | Moderna, Inc. | 1.23% | 30.42 | 0.0% | $648.09m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 6.40% | 231.15 | 1.9% | $560.63m | |
| ILMN | Illumina, Inc. | 1.84% | 273.99 | 3.5% | $491.54m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.63% | 87.06 | 2.0% | $275.41m | |
| A | Agilent Technologies, Inc. | 2.05% | 72.18 | 1.6% | $241.35m | |
| EXAS | EXACT Sciences Corp. | 0.94% | 58.45 | 21.0% | $207.42m | |
| INCY | Incyte Corp. | 3.77% | 71.56 | 2.5% | $173.86m | |
| SGEN | Seattle Genetics, Inc. | 4.47% | 114.15 | 6.1% | $169.53m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 3.72% | 82.47 | 4.3% | $166.32m | |
| NVAX | Novavax, Inc. | 10.50% | 14.42 | 114.7% | $165.70m | |
| CODX | Co-Diagnostics, Inc. | -10.38% | 8.20 | 0.0% | $133.09m |
Company Profile
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It offers instruments, reagents and services for molecular profiling applications. The firm serves biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.